StockWatch
·

Azad Engineering Ltd Q2 FY27 Results

AZADQ2 FY27 Results
Filing
Result:Steady· Market: Flat#Base effect#Margin expansion

Outlook: Cautiously Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue190.9410.6%31.1%
Total Income195.1010.8%23.6%
Expenditure153.6112.0%37.8%
PBT41.496.5%10.6%
Net Profit30.9312.0%5.2%
OPM37.85%0.56pp1.77pp
NPM15.85%4.11pp4.81pp
EPS4.7913.4%5.2%
View full financials

Revenue grew a strong 31.1% YoY with OPM expanding (36.1%→37.9%), but PBT/PAT fell YoY purely because other income collapsed (₹12.2cr→₹4.2cr) against a high prior-year base, while core operating profit (PBT ex-other income) actually rose ~9%, making this an in-line quarter on the sector's adjusted-profit lens despite healthy top-line momentum.

AZAD · Q2 FY27 · THE VERDICT

Record revenue, falling profit: Azad's capex trough gets real

Revenue up 31% and EBITDA margin at 37.9% — but net profit down 5.2% YoY. The quarter shows the cost of building out ₹1,300 crore of new capacity: depreciation, interest, and manpower are front-loaded, eating the operating gains.

14 Nov 2026 · 6 min read
Revenue

₹190.9 Cr

31.1% YoY; beats 25% long-term guidance

EBITDA margin

37.9%

vs 32–35% guidance band; +150 bps YoY

Net profit

₹30.9 Cr

-5.2% YoY; margin fell 160 bps to 15.8%

Operating cash flow

-₹45.8 Cr (H1)

Inventory +₹98 Cr, receivables +₹92 Cr; Q4 recovery flagged

The paradox of Azad's quarter: revenue soaring, EBITDA margin outperforming guidance — and profit falling. The 5.2% net-profit decline despite 31% revenue growth is the story. It is not an operational miss; it is capex absorption in motion.

Where the profit went

EBITDA grew 37.1% YoY to ₹70.4 Cr. Operating leverage is working. But the path from EBITDA to PAT is blocked by four cost lines, all front-loaded: depreciation ₹21.8 Cr (up ₹1.1 Cr YoY) from the GE Vernova facility commissioned September 2026; finance cost ₹12.2 Cr (up ₹3.8 Cr, +45% YoY) as debt funded the capex; manpower ₹50.3 Cr (up ₹17.8 Cr, +54%) teams hired ahead of revenue to staff new lines; and a tax provision on the shrinking pre-tax number. Together, they compressed PAT margin from 17.2% (H1 FY26) to 15.8% (Q2 FY27). A 160 bp loss in a single quarter — entirely structural, not competitive.

Margin delivery, %
014.1528.342.4537.9EBITDA margin17.2Prior-year PAT margin15.8Current PAT margin
Operating leverage is strong. Net margin compression is capex-driven: depreciation, interest, and labour costs front-loaded during ramp phase.
Management's claims vs. what holds up

Highest-ever quarterly revenue ₹187.8 Cr standalone; 31.6% YoY growth

Consolidated ₹190.9 Cr; YoY +31.1% — nearly identical to claimed 31.6%

Supported

EBITDA ₹70.4 Cr grew 37.1% YoY; margin 37.5%

Consolidated EBITDA margin 37.9% — well above stated 37.5% and guidance band

Supported (beats own claim)

PAT ₹30.8 Cr, margin 16.4%, profit stable sequentially

PAT ₹30.9 Cr at 15.8% margin; down 5.2% YoY and down 12% QoQ from Q1 ₹35.2 Cr

Contradicted

H1 PAT grew 6.6% YoY showing profit resilience

H1 growth 6.6% true, but Q2 alone shows -5.2% YoY; growth weighted by softer Q1

Overstated

Capacity setup complete; 80% of expansion stabilized in Q1

44,800 sq m GE Vernova facility commissioned Sep 2026; now production-ready; ramp begins Q3

Supported (capex on track)

Order book ₹6,500+ Cr; multi-year rolling contracts with deep visibility

Order book cited; 5–7 year rolling contract model; anchored by BHEL (₹52.68 Cr annually, extended 2030) and Baker Hughes (extended 2030)

Supported

What changed on this call

Margin guidance reaffirmed but profit guidance withdrawn. Management maintained 25%+ long-term revenue growth and 32–35% EBITDA margin band (delivered 37.9%, well above). But when asked for FY28 net income targets, MD Rakesh Chopdar deflected: 'I do not think, maybe next quarter I can update you exactly what would be the range.' This is de facto withdrawal of specific profit guidance — a first. Cost lag is now acknowledged as a multi-quarter phenomenon, not a one-quarter anomaly. New: the ₹1,300+ Cr ARR target by end FY28 — announced without fanfare but represents 1.7x growth from current ₹760 Cr run rate, higher than historical 25%+ guidance messaging and implicit acknowledgement of an acceleration phase ahead.

The bull-bear ledger

  • Record ₹190.9 Cr revenue, +31.1% YoY; H1 growth 29.3%, ahead of 25% guidance

  • EBITDA margin 37.9%, 150 bps expansion YoY, well above 32–35% guidance band

  • ₹6,500 Cr order book on 5–7 year rolling contracts; BHEL extended to 2030; supply chain locked in

  • 44,800 sq m GE Vernova facility live Sep 2026; 6 customer-dedicated lean lines; production-ready for Q3 ramp

  • Multiple OEM qualifications in final stages (Rolls-Royce 2 engines, Pratt & Whitney, Safran, GTRE); FY28 H1 aero engine revenue begins

  • PAT down 5.2% YoY despite 31% revenue growth — structural red flag on earnings quality

  • Net profit margin fell 160 bps YoY; profit guidance explicitly not quantified

  • Operating cash flow -₹45.8 Cr (H1); inventory bloat ₹425 Cr (+₹98 Cr), receivables ₹402 Cr (+₹92 Cr); Q4 stabilization timing uncertain

  • FII ownership fell 3.45 percentage points QoQ (16.15% Q1 FY26 → 12.70% Q2 FY27); institutional skepticism evident

  • Stock down 21.4% from all-time high ₹3,126 to ₹2,456; below 20-day and 50-day moving averages

  • 88% export exposure; geopolitical headwinds (US sanctions on Iran, EU trade shifts) could disrupt demand

  • Customer concentration risk: top customers unnamed; dedicated facilities create switching-cost lock-in but single-customer loss strands assets

Street positioning: why FII is selling

The market has priced in the profit miss. FII ownership collapsed 3.45 percentage points from Q1 FY26 (16.15%) to Q2 FY27 (12.70%), signalling institutional flight. The stock has been marked down 21% from its all-time high of ₹3,126, now trading at ₹2,456 — below its 20-day moving average (₹2,533) and 50-day MA (₹2,706), though above the 200-day MA (₹2,197). The RSI sits at 40.8, neutral. The selloff is logical: profit declined while capex burn persisted, cash conversion cycle extended, and management punted on earnings visibility. What the market is asking: Can Azad actually hit H2 acceleration and Q4 cash inflection, or is this a longer cycle than guided? FII's exit into weakness hints they are unsure.

Risks ranked by severity: what should concern a holder

Qualification timeline slippage

High

Rolls-Royce (2 engines), Pratt & Whitney, Safran, GTRE each typically carry 3–6 month buffer risks. Management says 'almost done' but no firm dates. Even a 3-month delay postpones ₹50–100 Cr revenue inflection and extends payback by one quarter.

Cash conversion cycle extension

High

H1 OCF -₹45.8 Cr with inventory +₹98 Cr and receivables +₹92 Cr. CFO expects Q4 swing, but macro headwinds (demand slowdown, customer payment delays) could delay the turnaround. Working capital intensity could persist into FY28.

PAT margin recovery uncertainty

High

Profit fell 5.2% despite 31% revenue growth. Depreciation, interest, and labour costs will rise further as new facilities ramp. Management provided no timeline for margin recovery to 17%+ levels. If fixed costs don't absorb as capacity utilizes, PAT could remain under pressure through FY28.

Customer and export concentration

Medium

88% export (primarily Mitsubishi, GE, Rolls-Royce, Safran, Baker Hughes). Top customers unnamed. Dedicated facilities create switching-cost lock-in but also mean facility-customer pairing: single-customer loss = stranded asset of ₹100+ Cr.

Interest cost rising, leverage rising

Medium

Finance cost +45% YoY to ₹12.2 Cr. Total debt ₹1.07 Cr; debt-to-equity 1.6x, debt-to-EBITDA 1.5x (healthy but rising). If capex extends or interest rates spike, cost pressure persists and PAT margin recovery slips.

Geopolitical disruption (sanctions, trade policy)

Medium

A&D segment (₹31.7 Cr, 17% of revenue) dependent on Rolls-Royce (UK), Safran (France), Pratt & Whitney (US). US sanctions on Iran reduce oil/gas engine demand. China competition in defence indigenization. Policy shifts could disrupt qualification timelines and demand.

What to watch next: three catalysts that resolve the debate
  • 1 · Q3 ramp acceleration (Oct–Dec 2026)

    GE Vernova and Mitsubishi dedicated lines must convert installed capacity into revenue. Watch for: (a) revenue growth acceleration vs. Q2 (guidance hints H2 will be stronger), (b) actual utilization rates on new lines (capacity installed ≠ revenue realized), and (c) first aero engine airfoil shipments to Rolls-Royce or Pratt & Whitney. Miss here extends pain into FY28.

  • 2 · Q4 cash inflection (Jan–Mar 2027)

    Operating cash flow must swing from -₹45.8 Cr (H1) to positive. CFO flagged this explicitly ('as throughput converts to revenue, inventory turns to receivable, then to cash'). This is the proof point for the capex thesis. If Q4 OCF is still negative or weakly positive, working capital management is worse than assumed, and FY28 earnings recovery becomes suspect.

  • 3 · FY28 H1 qualifications unlocking (Apr–Sep 2027)

    Rolls-Royce aero engine airfoil production revenue must begin. Pratt & Whitney and Safran qualifications must complete. Management flagged 'very soon' but gave no calendar dates. This is the ₹200–300 Cr revenue inflection that justifies the ₹1,300 Cr ARR target. Delays or failures here invalidate the long-term thesis. Track the press releases and earnings call tone for firmness of timelines.

Azad is executing a disciplined capex build, not stumbling. The paradox — record revenue and EBITDA margin strength paired with falling profit — is entirely structural: depreciation, interest, and manpower costs are front-loaded by design. The market's 21% pullback and FII exodus reflect legitimate timing risk, not fundamental failure. Azad is a Hold for investors already long, not a buy into strength.

The single number to track is operating cash flow. If H1's -₹45.8 Cr turns positive in Q4 as guided, the thesis is intact and FY28 earnings recovery is probable. If it doesn't, the ₹1,300 Cr ARR capacity target becomes optimistic and payback extends. Watch the cash. That is where the capex story either validates or ruptures.

Informational and educational content only. Not investment advice.